KN Knowles Corporation
Knowles Corporation offers capacitors, radio frequency (RF) and microwave filters, balanced armature speakers, and medtech microphones in Asia, the United States, Europe, rest of Americas, and internationally. It operates in two segments, Precision Devices (PD) and Medtech & Specialty Audio (MSA). The PD segment focuses on the custom design and delivery of high performance capacitor products and RF solutions primarily serving the defense, industrial, medtech, and electrification/energy markets. The MSA segment designs and manufactures balanced armature speakers and microphones for the hearing health; and specialty audio applications that serve the medtech and industrial markets. The company manufactures and sells film, electrolytic, and mica capacitors that are used in medtech, defense, and industrial electrification applications. It serves the defense, medtech, electric vehicle, industrial, and communications markets through original equipment manufacturers, their contract manufacturers, suppliers, sales representatives, and distributors. Knowles Corporation was founded in 1946 and is headquartered in Itasca, Illinois.…
Industry Peers
Electronic ComponentsKey Statistics
About Knowles (NYSE: KN)
›
Knowles (NYSE: KN) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Electronic Components industry, part of the Technology sector, and reports about 5,200 employees.
The shares were at 33.31 USD on 19 November 2026, up 53.9% over 52 weeks. Its 52-week range is 20.57 USD to 42.93 USD: the price is 22.4% below the high and 61.9% above the low.
At a market capitalisation of 2.82B USD, it trades at 38.3 times trailing earnings and 19.8 times forward earnings. The median trailing P/E of its 19 largest Electronic Components peers is 27.2, a premium of 41% for KN.
Knowles reports return on equity of 5.7%, an operating margin of 15.2% and revenue up 20.3% year over year.
Its debt exceeds its cash by 87.70M USD, a debt-to-equity ratio of 0.18. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 4 analysts cover the stock; their mean price target of 44.00 USD is 32.1% above the current price. The next earnings report is expected on 4 February 2027.